Jan Breslow

Q: What Schools Are Affiliated With Jan Breslow

Jan Breslow is affiliated with the following schools: University of California, Berkeley, Rockefeller University, University of Washington, Columbia University, Harvard University

Jan Breslow's AcademicInfluence.com Rankings

Jan Breslow

Biology

#4419

World Rank

#6588

Historical Rank

Biochemistry

#479

World Rank

#563

Historical Rank

biology Degrees

Download Badge

Biology

Jan Breslow's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is Jan Breslow Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jan Leslie Breslow is an American physician and medical researcher who studies atherosclerosis. As of 2017, he is Frederick Henry Leonhardt Professor at Rockefeller University and directs the university's Laboratory of Biochemical Genetics and Metabolism.

(See a Problem?)

Jan Breslow's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells (1992) (2278)
Low-density lipoprotein subclass patterns and risk of myocardial infarction. (1988) (1793)
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. (1994) (1723)
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. (1993) (1048)
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. (1998) (899)
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance (2001) (707)
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis (1989) (692)
Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. (1997) (614)
Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. (2004) (598)
Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. (1994) (594)
Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. (1977) (582)
Intracellular Cholesterol Transport (2004) (570)
n-3 fatty acids and cardiovascular disease. (2006) (556)
Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. (1990) (537)
ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. (1994) (518)
Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. (1981) (513)
Mouse Models of Atherosclerosis (1996) (471)
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. (1992) (450)
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. (1987) (447)
Whole population, genome-wide mapping of hidden relatedness. (2009) (426)
Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism (2001) (426)
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. (1982) (400)
Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. (2005) (394)
Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains one supplemental table. Published, JLR Papers in Press, August 1, 2003. DOI 10.1194/jlr.M300203-JLR200 (2003) (371)
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. (1989) (344)
Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. (1988) (343)
Human apolipoprotein E isoprotein subclasses are genetically determined. (1981) (343)
Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. (1985) (326)
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. (1991) (304)
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. (1995) (294)
Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. (1995) (290)
StAR-related Lipid Transfer (START) Proteins: Mediators of Intracellular Lipid Metabolism* (2003) (289)
Hepatic Scavenger Receptor BI Promotes Rapid Clearance of High Density Lipoprotein Free Cholesterol and Its Transport into Bile* (1999) (283)
Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. (1986) (281)
Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II (2000) (280)
Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. (1995) (279)
Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. (1991) (268)
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. (1987) (266)
Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. (1994) (262)
A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. (1990) (259)
Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. (1996) (259)
Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. (1992) (241)
An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. (1993) (240)
Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction (1992) (236)
Liver Receptor Homologue-1 Mediates Species- and Cell Line-specific Bile Acid-dependent Negative Feedback Regulation of the Apical Sodium-dependent Bile Acid Transporter* (2003) (236)
Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. (1980) (232)
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. (1998) (231)
Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. (1999) (229)
Recipes for creating animal models of diabetic cardiovascular disease. (2007) (222)
High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. (1989) (221)
Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. (1995) (218)
Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E—Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content (2001) (215)
Characterization of the major apolipoproteins secreted by two human hepatoma cell lines. (1981) (210)
Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. (1997) (208)
Scavenger Receptor BI (SR-BI) Is Up-regulated in Adrenal Gland in Apolipoprotein A-I and Hepatic Lipase Knock-out Mice as a Response to Depletion of Cholesterol Stores (1996) (204)
Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. (1985) (203)
Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. (2004) (201)
Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. (1994) (190)
Dietary and drug treatment of primary hyperlipoproteinemia. (1972) (186)
Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. (1996) (186)
Isolation and characterization of the human apolipoprotein A-I gene. (1983) (186)
Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. (1998) (182)
The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6 (2002) (177)
Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. (1996) (177)
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. (1982) (175)
Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. (1999) (174)
How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy? (2012) (172)
Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice (2002) (170)
Apolipoprotein genetic variation and human disease. (1988) (165)
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. (1989) (164)
Vitamin D May Not Improve Lipid Levels: A Serial Clinical Laboratory Data Study (2012) (161)
Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. (1998) (161)
Induction of Atherosclerosis by Low-Fat, Semisynthetic Diets in LDL Receptor–Deficient C57BL/6J and FVB/NJ Mice: Comparison of Lesions of the Aortic Root, Brachiocephalic Artery, and Whole Aorta (En Face Measurement) (2003) (160)
Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. (1984) (158)
Apolipoprotein E and the apolipoprotein E-deficient mouse. (1995) (158)
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. (1999) (155)
Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain (2002) (154)
Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. (1996) (151)
A Mouse Model with Features of Familial Combined Hyperlipidemia (1997) (148)
The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice. (1997) (148)
Cardiovascular disease burden increases, NIH funding decreases (1997) (144)
Linkage of human apolipoproteins A-I and C-III genes (1983) (143)
Transgenic mouse models of lipoprotein metabolism and atherosclerosis. (1993) (140)
Common SNPs in HMGCR in Micronesians and Whites Associated With LDL-Cholesterol Levels Affect Alternative Splicing of Exon13 (2008) (140)
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. (1993) (139)
Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. (1989) (137)
Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. (1989) (137)
Isolation and characterization of cDNA clones for human apolipoprotein A-I. (1982) (137)
Human apolipoprotein molecular biology and genetic variation. (1985) (136)
Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet (2009) (135)
Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. (2010) (135)
Genetic basis of lipoprotein disorders. (1995) (133)
An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis (1983) (132)
Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. (1991) (132)
Type of alcoholic beverage and risk of myocardial infarction. (1999) (131)
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. (1994) (130)
Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. (1998) (127)
Ultrastructure of early lipid accumulation in ApoE-deficient mice. (1999) (125)
Hepatic apo-A-I and apo-E and intestinal apo-A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues. (1982) (125)
Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. (1996) (124)
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. (1998) (122)
Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice. (1996) (121)
Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl ester lipase knockout mice. (1999) (121)
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. (1992) (121)
Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. (2000) (120)
Genome-Wide Association Studies in an Isolated Founder Population from the Pacific Island of Kosrae (2009) (117)
Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice. (1997) (116)
apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. (1995) (115)
Differential Gene Regulation of StarD4 and StarD5 Cholesterol Transfer Proteins (2005) (114)
The emergence of mouse models of atherosclerosis and their relevance to clinical research (1997) (113)
Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice. (1998) (113)
Inactive Lipoprotein Lipase (LPL) Alone Increases Selective Cholesterol Ester Uptake in Vivo, Whereas in the Presence of Active LPL It Also Increases Triglyceride Hydrolysis and Whole Particle Lipoprotein Uptake* (2002) (112)
Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide. (1983) (110)
Two Hsp70 family members expressed in atherosclerotic lesions (2003) (108)
Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. (1993) (107)
Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes (1988) (106)
Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia. (1980) (105)
Isoproteins of human apolipoprotein A-I demonstrated in plasma and intestinal organ culture. (1980) (103)
High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation (2004) (102)
Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. (1989) (102)
Orphan receptor HNF-4 and bZip protein C/EBP alpha bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. (1993) (101)
The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes (2007) (101)
Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. (1988) (101)
Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. (1992) (100)
Human Apolipoprotein A‐I‐C‐III Gene Complex is Located on Chromosome II (1984) (98)
ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. (1997) (98)
Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model (2001) (97)
A unique AT-rich hypervariable minisatellite 3' to the ApoB gene defines a high information restriction fragment length polymorphism. (1987) (96)
Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. (1999) (93)
A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. (2002) (93)
Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia (2005) (93)
Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3' to the gene in the promoter of the adjacent convergently transcribed apoC-III gene. (1993) (93)
Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. (2011) (92)
Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. (1995) (91)
The Short-Term Effects of Vitamin D Repletion on Cholesterol: A Randomized, Placebo-Controlled Trial (2012) (90)
Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice[S] (2009) (89)
Identification and DNA sequence of a human apolipoprotein E cDNA clone. (1982) (89)
In Silico Quantitative Trait Locus Map for Atherosclerosis Susceptibility in Apolipoprotein E–Deficient Mice (2003) (89)
Lipoprotein(a) reduction by N-acetylcysteine (1991) (87)
Epidemiology and Factor Analysis of Obesity, Type II Diabetes, Hypertension, and Dyslipidemia (Syndrome X) on the Island of Kosrae, Federated States of Micronesia (2000) (86)
Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium. (1999) (84)
U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. (1998) (84)
Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. (1994) (82)
Induced Mutant Mice Expressing Lipoprotein Lipase Exclusively in Muscle Have Subnormal Triglycerides yet Reduced High Density Lipoprotein Cholesterol Levels in Plasma* (1997) (81)
Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. (1994) (80)
Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia. (2006) (80)
Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII. (1984) (79)
Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae. (2009) (79)
Genetic basis of lipoprotein disorders. (1989) (78)
Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E. (1983) (75)
Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. (1991) (74)
Human apolipoprotein CIII gene expression is regulated by positive and negative cis-acting elements and tissue-specific protein factors. (1988) (74)
Evaluating potential for whole-genome studies in Kosrae, an isolated population in Micronesia (2006) (74)
A DNA insertion in the apolipoprotein A-I gene of patients with premature atherosclerosis (1983) (74)
Needed: pragmatic clinical trials for statin-intolerant patients. (2011) (73)
Effect of egg cholesterol and dietary fats on plasma lipids, lipoproteins, and apoproteins of normal women consuming natural diets. (1987) (72)
DASH: a method for identical-by-descent haplotype mapping uncovers association with recent variation. (2011) (72)
Plasma-exchange therapy of homozygous familial hypercholesterolemia. (1980) (71)
Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease. (1982) (69)
Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL/6 apolipoprotein E knockout mice. (2000) (68)
Preparation of individual human diploid fibroblasts and study of ion transport. (1985) (68)
Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women (2018) (68)
Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol of strict vegetarians. An experiment and a critical review. (1983) (68)
Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice (2001) (66)
Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. (1991) (66)
Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. (1999) (65)
The human apolipoprotein C-II gene sequence contains a novel chromosome 19-specific minisatellite in its third intron. (1987) (64)
Genetic differences in endothelial cells may determine atherosclerosis susceptibility. (2000) (64)
ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice. (1999) (64)
Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus. (1993) (64)
A20, a regulator of NFκB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains (2003) (63)
Genetic mutations affecting human lipoprotein metabolism. (1985) (62)
Hyperglycemic Ins2AkitaLdlr−/− mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease[S] (2011) (61)
Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool (*) (1995) (61)
Physical exercise and reduced risk of nonfatal myocardial infarction. (1995) (60)
Human Cholesteryl Ester Transfer Protein Gene Proximal Promoter Contains Dietary Cholesterol Positive Responsive Elements and Mediates Expression in Small Intestine and Periphery While Predominant Liver and Spleen Expression Is Controlled by 5′-distal Sequences (1996) (58)
Characterization of an Enhancer Element in the Human Apolipoprotein C-III Gene That Regulates Human Apolipoprotein A-I Gene Expression in the Intestinal Epithelium (*) (1995) (58)
Mapping of the human APOB gene to chromosome 2p and demonstration of a two-allele restriction fragment length polymorphism. (1986) (58)
Increased ADAM17 mRNA Expression and Activity Is Associated With Atherosclerosis Resistance in LDL-Receptor Deficient Mice (2008) (56)
Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles. (1985) (56)
Human apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobases in length. (1985) (56)
Cholesterol, 7-ketocholesterol and 25-hydroxycholesterol uptake studies and effect on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in human fibroblasts. (1975) (55)
Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets. (1991) (54)
Absence of enhanced intimal thickening in the response of the carotid arterial wall to endothelial injury in hypercholesterolemic rats. (1976) (54)
Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. (2001) (53)
Methylation changes in the apolipoprotein AI gene during embryonic development of the mouse. (1991) (53)
A regulatory element in the ApoCIII promoter that directs hepatic specific transcription binds to proteins in expressing and nonexpressing cell types. (1989) (53)
Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice. (2006) (51)
Homozygous Familial Hypercholesterolemia (1975) (50)
Effects of a low fat diet with and without intermittent saturated fat and cholesterol ingestion on plasma lipid, lipoprotein, and apolipoprotein levels in normal volunteers. (1988) (49)
ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia. (1991) (48)
Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene. (1990) (48)
Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism[S] (2010) (47)
Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. (2002) (46)
Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. (1996) (46)
Cell type-specific expression of the human apoB gene is controlled by two cis-acting regulatory regions. (1988) (46)
Effects of Rapid Weight Loss on Systemic and Adipose Tissue Inflammation and Metabolism in Obese Postmenopausal Women (2017) (46)
A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in human hepatoma cell lines. (1990) (45)
Purification of arylsulfatase A from human urine. (1972) (45)
Effects of shrimp consumption on plasma lipoproteins. (1996) (44)
A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men. (2003) (43)
Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred. (1988) (43)
Localization of the PE methylation pathway and SR-BI to the canalicular membrane: evidence for apical PC biosynthesis that may promote biliary excretion of phospholipid and cholesterol. (2003) (43)
Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic. (1994) (43)
Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium. (1997) (42)
Quantitative Trait Locus Mapping of Genetic Modifiers of Metabolic Syndrome and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice: Identification of a Locus for Metabolic Syndrome and Increased Atherosclerosis on Chromosome 4 (2004) (42)
Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure. (1989) (42)
Accumulation of human apolipoprotein E in the plasma of transgenic mice. (1990) (41)
Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6J × CASA/Rk intercross (2002) (41)
Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia (1989) (41)
Dihydropteridine reductase deficiency associated with severe neurologic disease and mild hyperphenylalaninemia. (1979) (41)
Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis. (1978) (40)
Lipoprotein transport gene abnormalities underlying coronary heart disease susceptibility. (1991) (40)
STARD4 knockdown in HepG2 cells disrupts cholesterol trafficking associated with the plasma membrane, ER, and ERC (2012) (39)
ApoB gene MspI RFLP in exon 26 changes amino acid 3611 from Arg to Gln. (1988) (39)
Familial aggregation of total cholesterol, high density lipoprotein cholesterol and total triglyceride levels in plasma. (1980) (39)
Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial. (2014) (39)
Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility (1987) (38)
Regression of myointimal thickening following carotid endothelial injury and development of aortic foam cell lesions in long term hypercholesterolemic rats. (1977) (37)
Primary hyperlipoproteinemia in infants. (1973) (37)
Cholesterol feeding of mice expressing cholesterol 7α-hydroxylase increases bile acid pool size despite decreased enzyme activity (2004) (37)
An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population (1995) (37)
Methylation patterns of the human apoA-I/C-III/A-IV gene cluster in adult and embryonic tissues suggest dynamic changes in methylation during development. (1991) (37)
Effects of prostaglandin E1 and isoproterenol on cyclic AMP content of human fibroblasts modified by time and cell density in subculture. (1974) (35)
The structure of the mouse lipoprotein lipase gene: a B1 repetitive element is inserted into the 3' untranslated region of the mRNA. (1991) (35)
Increased power of mixed models facilitates association mapping of 10 loci for metabolic traits in an isolated population. (2011) (34)
Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma. (1989) (34)
Characterization of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: genomic, mRNA, and protein sequences with comparisons to other species. (1992) (34)
CYSTIC FIBROSIS: A DISORDER OFCALCIUM-STIMULATED SECRETION AND TRANSEPITHELIAL SODIUM TRANSPORT? (1982) (33)
Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. (1999) (32)
Alternative Splicing of the Human Cholesteryl Ester Transfer Protein Gene in Transgenic Mice (1996) (32)
Athsq1 Is an Atherosclerosis Modifier Locus With Dramatic Effects on Lesion Area and Prominent Accumulation of Versican (2008) (32)
Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice. (1991) (30)
Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice. (2001) (30)
Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport. (1981) (30)
Sequence and expression of Tangier apoA-I gene. (1988) (29)
Dexamethasone-resistant cystic fibrosis fibroblasts show cross-resistance to sex steroids (1978) (28)
Characterization of the mouse liver cell line FL83B. (1973) (28)
A randomized clinical trial in vitamin D-deficient adults comparing replenishment with oral vitamin D3 with narrow-band UV type B light: effects on cholesterol and the transcriptional profiles of skin and blood. (2017) (27)
The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1. (1998) (26)
Lipoprotein regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in rat liver cell cultures. (1977) (26)
Decreased HDL 2 and HDL 3 Cholesterol , Apo A-I and Apo AII , and Increased Risk of Myocardial Infarction (2005) (25)
Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice. (1997) (25)
Systematic haplotype analysis resolves a complex plasma plant sterol locus on the Micronesian Island of Kosrae (2009) (25)
Nuclear factors AF-1 and C/EBP bind to the human ApoB gene promoter and modulate its transcriptional activity in hepatic cells. (1990) (24)
Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia. (1990) (24)
Phytosterolemia on the island of Kosrae: founder effect for a novel ABCG8 mutation results in high carrier rate and increased plasma plant sterol levels. (2004) (24)
Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice. (2004) (23)
Clinical utility of lipid and lipoprotein levels during hospitalization for acute myocardial infarction (1999) (22)
Plasma and hepatic apoE isoproteins of nonhuman primates. Differences in apoE among humans, apes, and New and Old World monkeys. (1985) (22)
Altered Expression of Raet1e, a Major Histocompatibility Complex Class 1–Like Molecule, Underlies the Atherosclerosis Modifier Locus Ath11 10b (2013) (21)
Increased dexamethasone resistance of cystic fibrosis fibroblasts. (1977) (21)
Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans. (1987) (21)
Lipoprotein metabolism and atherosclerosis susceptibility in transgenic mice. (1994) (21)
Genetic markers for coronary heart disease (2001) (21)
Identification of quantitative trait loci affecting body composition in a mouse intercross (2006) (21)
Insights into lipoprotein metabolism from studies in transgenic mice. (1994) (21)
Comparison of Hypochromic Effect and Optical Rotation in Poly-L-glutamic Acid (1963) (20)
Loci controlling plasma non-HDL and HDL cholesterol levels in a C57BL /6J x CASA /Rk intercross. (2003) (20)
Antibodies to PCSK9: a superior way to lower LDL cholesterol? (2012) (19)
Molecular basis of five apolipoprotein B gene polymorphisms in noncoding regions. (1990) (19)
Pleiotropic drug resistance in cystic fibrosis fibroblasts: Increased resistance to cyclic AMP (1978) (17)
Plasma plant sterol levels: another coronary heart disease risk factor? (2005) (17)
Alternative polyadenylation of apolipoprotein B RNA is a major cause of B-48 protein formation in rat hepatoma cell lines transfected with human apoB-100 minigenes. (1994) (16)
Cholesteryl Ester Transfer Protein and Atherogenesis (1997) (16)
Metabolic Determinants of Low HDL‐C Levels (1993) (16)
Genetics of Lipoprotein Disorders (1993) (16)
Effect of lipoprotein on 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase activity in rat liver cell culture: special suppressant effect of a lipoprotein isolated from hypercholesterolemic rat plasma. (1975) (15)
Sequence polymorphism in the human apoB gene at position 8344. (1990) (15)
European admixture on the Micronesian island of Kosrae: lessons from complete genetic information (2009) (14)
Genetic determinants of myocardial infarction. (1995) (14)
Noninvasive Detection of Inflammatory Changes in White Adipose Tissue by Label-Free Raman Spectroscopy. (2016) (14)
The Mouse Atherosclerosis Locus at Chromosome 10 (Ath11) Acts Early in Lesion Formation With Subcongenic Strains Delineating 2 Narrowed Regions (2010) (13)
Increased resistance of cystic fibrosis fibroblasts to ouabain toxicity. (1977) (13)
Molecular genetics of lipoprotein disorders. (1984) (13)
Genetic Modifiers of Atherosclerosis in Mice (2001) (12)
[40] Intra- and extracellular modifications of apolipoproteins (1986) (12)
A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia). (1993) (12)
Pediatric aspects of hyperlipidemia. (1978) (12)
Serum stimulation of CCR7 chemotaxis due to coagulation factor XIIa-dependent production of high-molecular-weight kininogen domain 5 (2016) (12)
Elizabeth R. De Oliveira e Silva, David Foster, Monnie McGee Harper, Cynthia E. Transport Rate of Apolipoproteins A-I and A-II Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the (2006) (11)
Enhanced phosphorylation of many endogenous protein substrates in human fibroblasts transformed by simian virus 40. (1979) (11)
Genetic regulation of apolipoproteins. (1987) (11)
Sodium transport in cystic-fibrosis-fibroblast not different from normal. (1981) (11)
Vitamin D3 Repletion in Chronic Kidney Disease Stage 3: Effects on Blood Endotoxin Activity, Inflammatory Cytokines, and Intestinal Permeability (2013) (10)
Allele frequencies of apolipoprotein A-I and A-II gene locus DNA polymorphisms in Boston-based whites. (1989) (8)
Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4). (2002) (8)
N-acetylcysteine and lipoprotein(a) (1992) (8)
Cardiovascular disease myths and facts. (1998) (7)
Novel Strategy Using F1-Congenic Mice for Validation of QTLs: Studies at the Proximal Chromosome 10 Atherosclerosis Susceptibility Locus (2009) (7)
Docosahexaenoic Acid Supplementation is Not Anti-Inflammatory in Adipose Tissue of Healthy Obese Postmenopausal Women. (2017) (7)
Decreased ouabain binding in cystic fibrosis fibroblasts in potassium-free medium. (1977) (6)
Excess dietary fructose does not alter gut microbiota or permeability in humans: A pilot randomized controlled study (2021) (6)
Obesity and ethnicity alter gene expression in skin (2020) (6)
Sodium transport in cystic fibrosis fibroblasts. (1981) (6)
The genetic basis of lipoprotein disorders Introduction and overview (1992) (6)
Two loci on chromosome 9 control bile acid composition: evidence that a strong candidate gene, Cyp8b1, is not the culprits⃞ Published, JLR Papers in Press, June 8, 2006. (2006) (5)
Homozygous familial hypercholesterolemia. A possible biochemical explanation of clinical heterogeneity. (1975) (5)
ApoE distribution among lipoproteins of rhesus monkeys is modulated by dietary fat and cholesterol. (1986) (5)
Perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals. (2014) (5)
Longitudinal study shows increasing obesity and hyperglycemia in micronesia (2013) (5)
A complex plasma plant sterol locus on mouse chromosome 14 has at least two genes regulating intestinal sterol absorption Published, JLR Papers in Press, July 13, 2006. (2006) (5)
Chapter 12 Lipoprotein genetics and molecular biology (1987) (5)
Why You Should Support the American Heart Association! Presented at the 69th Scientific Sessionsof the American Heart AssociationNovember 10, 1996New Orleans, Louisiana (1996) (4)
Characterization of the apolipoprotein A-I-C-III gene complex. (1986) (4)
Discoordinate regulation of the ileal bile acid transporter (ASBT) and bile acid binding protein (ILBP) in mouse ileum (2000) (4)
[120] Cerebroside sulfate sulfatase (arylsulfatase A) from human urine (1972) (4)
Lipoproteins and Heart Disease (1994) (4)
TWO DIMENSIONAL MAPS OF HUMAN APOLIPOPROTEINS IN NORMAL AND DISEASED STATES (1980) (4)
Clinical use of genetic typing in human lipid disorders. (2012) (4)
Apolipoprotein genes and atherosclerosis (1992) (4)
Increased ADAM 17 mRNA Expression and Activity Is Associated With Atherosclerosis Resistance in LDL-Receptor Deficient Mice (2008) (3)
Genetic susceptibility to atherosclerosis. (1989) (3)
Human osteogenic sarcoma cells exhibit enhanced protein phosphorylation. (1981) (3)
Learning experiences during the internship year: an exploratory study of pediatric graduate education. (1973) (3)
Apolipoprotein A-I gene expression in transgenic mice. (1991) (3)
Effect of fosinopril and vitamin E on LDL peroxidation and atheroclerosis progression in apo E-deficient mice (1995) (2)
Excess dietary fructose does not alter gut microbiota or permeability in humans: A randomized controlled pilot study (2020) (2)
Differential killing of normal and cystic fibrosis fibroblasts by dexamethasone. (1980) (2)
Isolation of cDNA and genomic clones for apolipoprotein C-II. (1986) (2)
Apolipoprotein Gene Mutations, Dyslipoproteinemia and Coronary Heart Disease (1987) (2)
Intra- and extracellular modifications of apolipoproteins. (1986) (2)
3-HYDROXY-3 METHYL GLUTARYL COENZYME A (HMG COA) REDUCTASE ACTIVITY IN FIBROBLASTS FROM PHENOTYPIC HOMOZYGOUS TYPE II HY-PERLIPOPROTEINEMIA (HHLPII) (1974) (1)
Apolipoprotein defects. (1985) (1)
High density lipoprotein and heart disease: induced mutant mouse studies. (1996) (1)
Isolation and characterization of the apolipoprotein genes. (1985) (1)
DECREASED OUABAIN BINDING IN CYSTIC FIBROSIS FIBROBLASTS (1977) (1)
514 CYSTIC FIBROSIS FIBROBLASTS SHOW ENHANCED DEXAMETHA-SONE RESISTANCE (1978) (1)
Apolipoprotein E (2004) (1)
Acknowledgment to Reviewers (2019) (1)
26 Vlcd-Induced Rapid Weight Loss Is Accompanied by Enhanced Lipolysis, Altered Adipose Tissues With Concomitant Changes in the Fecal Microbiome and Plasma Metabolome (2016) (1)
Muscle specific overexpression of human lipoprotein lipase in transgenic mice (1995) (1)
Abstract: 1503 GENETIC LOCI SHOW INVERSE EFFECTS ON PLASMA PHYTOSTEROLS IN MICE (2009) (0)
Apolipoprotein AI overexpression remodels large, complex atherosclerotic lesions to have characteristics of more stable plaques in apoE-deficient mice (2001) (0)
Plasma and lipoprotein oxidation in apo E-deficient mice with severe hypercholesterolemia and atherosclerosis (1994) (0)
Human ApoA-I 1 Inhibits the Hydrolysis of HDL Triglyceride and the Decrease of HDL Size Induced by Hypertriglyceridemia and Cholesteryl Ester Transfer Protein in Transgenic Mice (2013) (0)
Genomewide association studies and lipid risk factors (2009) (0)
Algal DHA Affects Plasma Lipoprotein Particle Size Distribution in Overweight (2010) (0)
2229 A community-academic translational research and learning collaborative to evaluate the associations among biological, social, and nutritional status for adolescent women and their babies using electronic health records (EHR) data (2018) (0)
Epidemiology and Prevention Vitamin D May Not Improve Lipid Levels (2012) (0)
Physiological apolipoprotein E epsilon-3 and epsilon-4 isoforms promote fibrillogenesis of A-beta in a thioflavine T assay (1995) (0)
Phytosterolemia on the island of Kosrae Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400006-JLR200 (2004) (0)
Remodel Lesions Without Suppressing Indices of Inflammation or Oxidation High-Density Lipoproteins Retard the Progression of Atherosclerosis and Favorably (2004) (0)
Isolation and characterization of cDNA clones corresponding to two different human apoC-l I I alleles (2002) (0)
Use of transgenic animals in lipoprotein research (1990) (0)
Abstract 19704: Tribbles Homolog-1 (Trib1) Deficiency Promotes Hyperlipidemia, Inflammation and Atherosclerosis in Mice Lacking the LDL-Receptor (2016) (0)
Genetic determinants of dyslipidemias. (1985) (0)
A murine desensitization model to interrogate the Factor XII‐mediated contact system in allergic inflammation.: 573 (2019) (0)
1.C.1 Induced mutant mouse models of lipoprotein disorders and atherosclerosis (1997) (0)
Enhancedphosphorylation ofmanyendogenous protein substrates in humanfibroblasts transformed bysimian virus 40 (1979) (0)
Mo-W9:3 StAR-related lipid transfer proteins in intracellular cholesterol metabolism (2006) (0)
PRIMARY HYPERLIPOPROTEINE MIA IN INFANTS 7082 (1973) (0)
The Application of Spearman Partial Correlation for Screening Predictors of Weight Loss in a Multiomics Dataset. (2022) (0)
Genetic Susceptibility to Atherosclerosis Participants (2005) (0)
Effect of Triglycerides on HDL Metabolism (1992) (0)
Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women (2018) (0)
Author Correction: Obesity and ethnicity alter gene expression in skin (2021) (0)
Adipose tissue measurements of computed tomography scan studies as a possible predictor of cancer recurrence after radical prostatectomy (2018) (0)
Tu-P7:46 Identification of atherosclerosis susceptibility genes at a quantitative trait locus (QTL) on mouse chromosome 19 (2006) (0)
Obesity and Race Alter Gene Expression in Skin (2020) (0)
Human ApoA-I1 Inhibits the Hydrolysis of HDL Triglyceride and the Decrease of HDL Size Induced by Hypertriglyceridemia and Cholesteryl Ester Transfer Protein in Transgenic Mice (0)
1.P.25 Induction of human apoprotein A-I gene expression in transgenic mice with nephrotic syndrome (1997) (0)
2184: Evaluating the association among biological, social, and nutritional status on adolescent pregnancy rates, physiology and birth outcomes using electronic health records data (2017) (0)
TRIB1, chromosome 8 and the regulation of blood lipids (2011) (0)
Effect of"fast track" admission foracute myocardial infarction ondelay tothrombolysis (1992) (0)
Plasma Plant Sterol Levels (2004) (0)
3T3-L1 adipocytes. mouse expression at the transcriptional level in downregulates lipoprotein lipase gene factor but not interleukin-1 alpha Recombinant human cachectin/tumor necrosis (2013) (0)
Loci controlling plasma non-HDL and HDL cholesterol levels in a C57BL /6J × CASA /Rk intercross Published, JLR Papers in Press, June 16, 2003. DOI 10.1194/jlr.M300139-JLR200 (2003) (0)
mRN 4 in human hepatoma cell lines (2002) (0)
Lipoproteins and heart disease. Transgenic mice models are helping in the search for new therapies. (1994) (0)
Altered Expression of Raet1e , an MHC Class 1–Like Molecule, Underlies the Atherosclerosis Modifier Locus Ath11 10b (2013) (0)
2153 The plasma contact system and its role in common variable immunodeficiency (CVID): An explorative study (2018) (0)
Immuno-laser capture microdissection (LCM) enriches macrophage foam cell RNA for the molecular analysis of atherosclerotic lesions (2002) (0)
Why you should support the American Heart Association! Presented at the 69th scientific sessions of the American Heart Association. November 10, 1996. New Orleans, Louisiana. (1996) (0)
Transgenic mouse models of lipoprotein metabolism and atherosclerosis ( apolpoprotein / diet / colester ) (2005) (0)
117 GENETIC VARIATION IN APOLIPOPROTEIN E. A CLUE TO ATHEROSCLEROSIS SUSCEPTIBILITY? (1981) (0)
We-W35:5 ADAM17: A new candidate gene of atherosclerosis susceptibility identified by quantitative trait locus mapping in LDL-receptor deficient mice (2006) (0)
Intracellular and extracellular processing of human apolipoprotein A-I: Secreted apolipoprotein A-I isoprotein 2 is a propeptide (high density lipoproteins/apolipoprotein A-I converting disease/signal peptide/lipoprotein and (0)
Abstract 21720: Tribbles Homolog-1 (Trib1) Gene Deficiency Causes Mixed Hyperlipidemia in Mice by Increasing Hepatic Lipogenesis and VLDL Production (2010) (0)
Genetic lipoprotein abnormalities producing high blood cholesterol. (1992) (0)
Genome-Wide Association Studies in an Isolated Founder Population from the Pacific Island of Kosrae Citation Lowe (2009) (0)
Dietary monounsaturated fatty acids and carbohydrates increase VLDL-cholesterol and atherosclerosis in mice via an apo E dependent pathway (2000) (0)
3389 Coagulation Factor Xll-mediated contact system and its role in adaptive and innate immune cell movement (2019) (0)
2184 (2017) (0)
Screening Predictors of Weight Loss: An Integromics Approach (2020) (0)
Purification and Properties of Two Sphingolipid Hydrolases (1972) (0)
Abstract 1648: Chromosome 14 Plasma Plant Sterol Locus 14DKK Subcongenic Mice Show Decreased Sterol Absorption and Impaired Bile Acid Metabolism through a Mechanism that May Involve Fibroblast Growth Factor 15 (Fgf15) Signaling (2006) (0)
Letter to the Editor: Differential Killing of Normal and Cystic Fibrosis Fibroblasts by Dexamethasone (1980) (0)
Localization of the PE methylation pathway and SR-BI to the canalicular membrane Published, JLR Papers in Press, June 16, 2003. DOI 10.1194/jlr.M200488-JLR200 (2003) (0)
Abstract 1192: Increased ADAM17 Activity is Associated with Atherosclerosis Resistance in LDL-receptor-deficient Mice (2007) (0)

This paper list is powered by the following services:

Other Resources About Jan Breslow

en.wikipedia.org

What Schools Are Affiliated With Jan Breslow?

Jan Breslow is affiliated with the following schools:

Jan Breslow's Academic­Influence.com Rankings